Angina Pectoris: Clinical Trials

55 trials for Angina Pectoris, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

55 completed. 55 Phase 2, 7 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 255Completed 55
Phase 37Completed 7
Phase 13Completed 3

Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris

Trials (filtered) newest first · largest first

All 55 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Vericiguat on Microvascular Function in Patients With Documented Vasospastic Angina Pectoris
Vericiguat - Vasospastic Angina
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)572025-02-102026-07-29
Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)
AdVEGFXC1 - Coronary Artery Disease, Ischemia
Phase 1 / Phase 2CompletedXyloCor Therapeutics, Inc.412020-01-242024-01-30
Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris
AdvVEGF-D, Control Rx - Refractory Angina Pectoris, Gene Transfer
Phase 2CompletedKuopio University Hospital632019-10-192025-01-13
Precision Medicine With Zibotentan in Microvascular Angina
Zibotentan, Placebo oral tablet - Microvascular Angina
Phase 2CompletedNHS Greater Glasgow and Clyde2252019-10-182023-08-04
The Randomized OPTIMAL-ACT Trial
Unfractionated heparin - Coronary Artery Disease, Ischemic Heart Disease
Phase 2CompletedMayo Clinic1802019-02-082023-04-04
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Ticagrelor, Eptifibatide, Clopidogrel - Acute Coronary Syndrome, Angina, Unstable
Phase 2CompletedUniversity of Alabama at Birmingham1002016-11-012020-05-04
Treadmill Cardiovascular Safety Study of Erenumab (AMG 334)
Erenumab, Placebo - Stable Angina
Phase 2CompletedAmgen892015-11-232018-08-24
Investigating the Effects of Dietary Nitrate on Vascular Function, Platelet Reactivity and Restenosis in Stable Angina
Beetroot Juice - Cardiovascular Diseases
Phase 2CompletedQueen Mary University of London3002015-11-022025-06-11
A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome
Acetylsalicylic acid, Rivaroxaban, Clopidogrel - Acute Coronary Syndrome
Phase 2CompletedJanssen Research & Development, LLC30372015-04-202017-12-26
Ranolazine Among Unrevascularized Chronic Stable Angina Patients
Ranolazine, Sugar pill - Angina
Phase 2CompletedNorth Florida Foundation for Research and Education502014-09-012019-08-22
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
Ranolazine, Placebo - Microvascular Angina
Phase 2CompletedEmory University262014-09-012019-05-21
Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
CMX-2043, Placebo comparator - Non STEMI, Unstable Angina
Phase 2CompletedIschemix, LLC3612014-06-012016-02-23
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
Liraglutide, Placebo - Ischaemic Heart Disease, Coronary Heart Disease
Phase 2CompletedKing's College London262014-01-012015-05-20
The Effects of Inorganic Nitrate on Cardiac Muscle in Angina
Sodium Nitrate, Placebo - Chronic Stable Angina
Phase 2CompletedUniversity of Aberdeen702012-10-012015-11-05
Intracardiac CD133+ Cells in Patients With No-option Resistant Angina
intramyocardial injection (electromechanical mapping based), Placebo - Stable Angina
Phase 2CompletedMedical University of Silesia312012-06-012017-09-28
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Short Tirofiban, Eptifibatide, Long Tirofiban - Myocardial Infarction, Acute Coronary Syndromes
Phase 2CompletedMedicure5352012-04-012021-05-13
Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting
Acetylsalicylic acid - Coronary Artery Bypass Surgery, Stable Angina
Phase 2 / Phase 3CompletedKarolinska University Hospital452011-12-012018-03-08
Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina
Placebo - Variant Angina
Phase 2CompletedKorea Otsuka Pharmaceutical Co., Ltd.502011-10-012012-07-16
Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
Nasal oxygen, Regular nasal air - Angina
Phase 2CompletedRegion Skane3002011-07-012012-08-10
Comparison of Drug Eluting Balloon and Drug Eluting Stent
Drug eluting balloon + Bare metal stent, drug eluting stent (Zotarolimus-eluting stent) - Coronary Artery Disease, Stable Angina
Phase 2CompletedSeoul National University Bundang Hospital1802011-04-012015-06-12

Showing 20 of 55. Sign in to see all of them.

Narrower conditions

Angina, Stable (18)  ·  Angina, Unstable (17)  ·  Coronary Artery Disease (17)  ·  Myocardial Infarction (14)  ·  Myocardial Ischemia (8)  ·  Acute Coronary Syndrome (6)  ·  Chest Pain (4)  ·  Heart Failure (4)  ·  Non-ST Elevated Myocardial Infarction (4)  ·  Cardiovascular Diseases (3)  ·  Coronary Disease (3)  ·  Microvascular Angina (3)  ·  Angina Pectoris, Variant (2)  ·  Atherosclerosis (2)

Broader conditions

Vascular Diseases (55)  ·  Heart Diseases (54)  ·  Neurologic Manifestations (54)  ·  Pain (54)  ·  Pathological Conditions, Signs and Symptoms (54)  ·  Signs and Symptoms (54)  ·  Cardiovascular Diseases (52)  ·  Chest Pain (50)  ·  Myocardial Ischemia (47)  ·  Pathologic Processes (22)  ·  Infarction (18)  ·  Ischemia (18)  ·  Necrosis (18)  ·  Arterial Occlusive Diseases (17)

Interventions

Clopidogrel (5)  ·  Aspirin (4)  ·  Ticagrelor (4)  ·  Eptifibatide (3)  ·  Abciximab (2)  ·  Heparin (2)  ·  Influenza Vaccines (2)  ·  Ranolazine (2)  ·  STA 2 (2)  ·  Tirofiban (2)  ·  1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one (1)  ·  Adenosine (1)  ·  Amlodipine (1)  ·  Atorvastatin (1)  ·  Capsules (1)

Sponsors

AstraZeneca (2)  ·  Shahid Beheshti University of Medical Sciences (2)  ·  Sinphar Pharmaceutical Co., Ltd (2)  ·  ARCA Biopharma, Inc. (1)  ·  Ablynx, a Sanofi company (1)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Amgen (1)  ·  Anthera Pharmaceuticals (1)  ·  Antwerp Cardiovascular Institute Middelheim (1)  ·  Biopure Corporation (1)  ·  Boehringer Ingelheim (1)  ·  Cardium Therapeutics (1)  ·  Celgene (1)  ·  CellPraxis Bioengenharia Ltda. (1)  ·  Corewell Health East (1)

Countries

United States (22)  ·  Belgium (9)  ·  United Kingdom (9)  ·  Netherlands (8)  ·  Canada (6)  ·  Germany (6)  ·  Poland (5)  ·  Russia (5)  ·  Czechia (4)  ·  Denmark (4)  ·  South Korea (4)  ·  Sweden (4)  ·  Brazil (3)  ·  Bulgaria (3)  ·  Hungary (3)

Top investigators

Ali Eskandari, MD (2)  ·  Chuen-Den Tseng, MD, Ph.D (2)  ·  Hossein Vakili, M.D. (2)  ·  Maryam Keshtkar-Jahromi, M.D.; M.P.H. (2)  ·  Seyed Mostafa Razavi, MD (2)  ·  Sharareh Gholamin, MD (2)  ·  Alan S Lader, PhD (1)  ·  Amrita Ahluwalia, PhD (1)  ·  Andrew A Wolff, MD, FACC (1)  ·  Annapoorna S Kini, MD MRCP (1)  ·  Anthony A Bavry, MD, MPH (1)  ·  Boris Nasseri, MD (1)  ·  Christof Stamm, MD (1)  ·  David Leibowitz, MD (1)

Results publications

PMID 21079055, PMID 22212857, PMID 22795280, PMID 17174178, PMID 17320744, PMID 17599602, PMID 17631219, PMID 17825712, PMID 18188136, PMID 19608137, PMID 19608488, PMID 19923168, PMID 20194878, PMID 20226548, PMID 20620737, PMID 20863951, PMID 21411144, PMID 21737787, PMID 22027731, PMID 22447880, PMID 22964356, PMID 23137499, PMID 23394404, PMID 23413981, PMID 23957447, PMID 24497345, PMID 24934484, PMID 25136078, PMID 25453536, PMID 25651246, PMID 25760881, PMID 26995378, PMID 27151378, PMID 27730819, PMID 27903568, PMID 27998900, PMID 28325638, PMID 28480650, PMID 28887315, PMID 31141104, PMID 31535314, PMID 31766977, PMID 32719097, PMID 33272036, PMID 33579317, PMID 34224684, PMID 37503661, PMID 38696284, PMID 39217504, PMID 39469537

NIH funding

2008 (1), 2014 (1), 2015 (1), U01HL087318 (1)